Amyris, Inc.
Case Number:
1:23-bk-11131
Court:
Nature of Suit:
Firms
- ArentFox Schiff
- Arnold & Porter
- Ballard Spahr
- Barack Ferrazzano
- Benesch
- Bielli & Klauder
- Blank Rome
- Bragar Eagel
- Buchalter APC
- Cole Schotz
- Cross & Simon
- Cyrulnik Fattaruso
- deLeeuw Law
- DLA Piper
- Duane Morris
- Foley Hoag
- Fox Rothschild
- Golenbock Eiseman
- Goodwin Procter
- Greenberg Traurig
- Harris Beach PLLC
- Holland & Knight
- Keller & Heckman
- KTBS Law
- Kudman Trachten
- Landis Rath
- Latham & Watkins
- Lewis Brisbois
- Linebarger Goggan
- Margolis Edelstein
- McCarter & English
- MoloLamken
- Monzack Mersky
- Morris James
- Morris Nichols
- Nixon Peabody
- Ostrager Chong
- Pachulski Stang
- Paul Hastings
- Paul Weiss
- Potter Anderson
- Powell Firm
- Richards Layton
- Rosner Law Group LLC
- Streusand Landon
- Tannenbaum Helpern
- Troutman Pepper
- Tucker Arensberg
- White and Williams
- White & Case
- Womble Bond
- Young Conaway
Companies
- Amyris Inc.
- Cosan Limited
- Dr. Reddy's Laboratories Ltd.
- Givaudan
- Google LLC
- Hearst Corp.
- Jefferies Financial Group Inc.
- Microsoft Corp.
- NTT Data Corp.
- Oracle Corp.
- Salesforce.com Inc.
- Sartorius AG
- Sephora SA
- Stretto Inc.
- Thermo Fisher Scientific Inc.
- U.S. Bancorp
Government Agencies
Sectors & Industries:
-
August 11, 2023
Amyris Ok'd To Tap Part Of $190M DIP Loan For Quick Ch. 11
Biochemical company Amyris Inc. on Friday secured a debtor-in-possession loan of $190 million, all new money, from one of its lenders to fund an expedited Chapter 11 process, giving it 35 days to come up with a Chapter 11 plan all its creditors will approve.
-
August 10, 2023
Bio Venture Amyris Files Ch. 11 With $1.1B In Debt
Synthesized biologicals producer Amyris Inc. filed for Chapter 11 protection in Delaware bankruptcy court Thursday, saying it needs to reorganize and sell off non-core businesses in the face of more than $1.1 billion in debt.
- ← Previous
- 1
- 2
- 3
- Next →